Supriya Life gains on securing CEP for anti-histamine therapy 0 29.09.2022 07:06 Business Standard Supriya Lifescience rose 1.52% to Rs 300.85 after the company said it received Certification of Suitability for anti-histamine therapy from the European Directorate for the Quality of Medicines and HealthCare. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
